December 1, 2022 Target was Hit on AbbVie Inc. for a 13.6% Gain. Target was Hit on AbbVie Inc. (ABBV) at $162 for a 13.6 Gain. (Long Term Portfolio)
Leave a Reply
You must be logged in to post a comment.